e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of a
1
-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review
Ignacio Blanco, Isidro Diego, Patricia Bueno, Sergio Pérez-Holanda, Francisco Casas-Maldonado, Marc Miravitlles
Source:
Eur Respir Rev, 29 (157) 200014; 10.1183/16000617.0014-2020
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ignacio Blanco, Isidro Diego, Patricia Bueno, Sergio Pérez-Holanda, Francisco Casas-Maldonado, Marc Miravitlles. Prevalence of a
1
-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review. Eur Respir Rev, 29 (157) 200014; 10.1183/16000617.0014-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
Anemia in COPD patients in Spain: A systematic review
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Prevalence of undiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Prevalence of COPD by severity level: systematic review and meta-analysis
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report
Source: Eur Respir J 2005; 26: Suppl. 49, 440s
Year: 2005
Alpha1-antitrypsin levels and phenotypes in COPD patients in Kyrgyz population
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Misdiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007
Pulmonary hypertension in COPD patients: a systematic review and meta-analysis
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
Epidemiological burden of moderate-to-very severe COPD: a systematic literature review
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study.
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
The prevalence and related factors of fatigue in patients with COPD: a systematic review
Source: Eur Respir Rev, 30 (160) 200298; 10.1183/16000617.0298-2020
Year: 2021
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Alpha-1-antitrypsin deficiency in Kazakh subjects with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Alpha1-antytripsin deficiency in portuguese COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Epidemiology of chronic obstructive pulmonary disease in Brazil: a systematic review and meta-analysis
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Prevalence of COPD: updated meta-analysis results
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept